Crescent Biopharma, Inc. (CBIO) — Capital Reinvestment Ratio
Crescent Biopharma, Inc. (CBIO) has a Capital Reinvestment Ratio of 0.00x as of September 2015, meaning it reinvests 0% of its operating cash flow ($13.56 Million) in capital expenditures ($58.39K). Check Crescent Biopharma, Inc. (CBIO) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Crescent Biopharma, Inc. Capital Reinvestment Ratio (2011–2011)
This chart tracks Crescent Biopharma, Inc.'s Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Crescent Biopharma, Inc. cash flow conversion.
Annual Capital Reinvestment Ratio for Crescent Biopharma, Inc. (2011–2011)
Year-by-year Capital Reinvestment Ratio for Crescent Biopharma, Inc. from 2011 to 2011. See CBIO FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 0.01x | $13.85 Million | $182.44K | — |